Here’s the pitch deck that convinced Salesforce CEO Marc Benioff to participate in a $33 million Series C extension for Vineti, which makes cloud software to track advanced drug development
Vineti, a cloud software startup that manages the development of drugs such as cancer vaccines and cell and gene therapies recently raised a $33 million extension to its Series C round. Business Insider recently interviewed Vineti CEO and Co-founder Amy DuRoss about the company, why it raised an extension to its Series C round, and how it was able to attract Salesforce CEO Marc Benioff as an investor. The COVID-19 pandemic created a slowdown in the development and commercialization of some drugs and therapies that had...